A C185181 PQ/CMC Expiration Date Classification Terminology C48660 Not Applicable Determination of a value is not relevant in the current context. Not Applicable NA Determination of a value is not relevant in the current context. A C185183 PQ/CMC Retest Date Classification Terminology C48660 Not Applicable Determination of a value is not relevant in the current context. Not Applicable NA Determination of a value is not relevant in the current context. A C133846 PQ/CMC Batch Utilization Terminology C185328 Stability Study Batch A batch placed under study to determine the maintained performance parameters over time. Stability Study A batch placed under study to determine the maintained performance parameters over time. A C133856 PQ/CMC Impurity Classification Terminology C134001 Inorganic Impurity Any unwanted inorganic compound generated during the manufacturing process of a particular substance or product. Inorganic Materials that are not carbon-based and are generated during a manufacturing process that are not part of elemental impurity specification. A C133856 PQ/CMC Impurity Classification Terminology C176815 Residual Solvent Inorganic or organic liquids added during the manufacturing process. Residual Solvent Inorganic or organic liquids added during the manufacturing process. [Source: Adapted from ICH Q3A(R2)] A C133856 PQ/CMC Impurity Classification Terminology C176816 Degradant An impurity resulting from a chemical change in the drug substance. Degradation Product A molecule resulting from a chemical change brought about over time and/or by the action of something (e.g., light, temperature, pH, water, or by reaction with an excipient and/or the immediate container/closure system). [Source: SME Defined] A C133856 PQ/CMC Impurity Classification Terminology C185190 Elemental Impurity Elements that are found in the environment or that are used or introduced in the manufacture of drug substances or excipients. Elemental Impurities Elements that are found in the environment or that are used or introduced in the manufacture of drug substances or excipients. [Source: Elemental Impurities - Information, USP Pharmacopeial Forum, Vol. 36(1)] A C133856 PQ/CMC Impurity Classification Terminology C185192 Leachable Material Materials that can migrate from manufacturing systems, container-closure systems and drug-delivery components. Leachables Materials that can migrate from manufacturing systems, container-closure systems and drug-delivery components. [Source: Adapted from ICH Q3E Concept Paper] A C133856 PQ/CMC Impurity Classification Terminology C92081 Microbial Contamination The undesirable presence of microorganisms or microbes such as bacteria and fungi (yeasts and molds). Microbiological Microorganism contamination of the cell culture or starting/raw materials that are objectionable due to their detrimental effect on products or potential harm to patients or due to the total number of organisms. [Source: 21CFR211 Preamble]. Examples: bacteria, fungi, mollicutes (mycoplasmas or spiroplasmas), mycobacteria, rickettsia, protozoa, parasites, agents causing TSEs and viruses. A C185181 PQ/CMC Expiration Date Classification Terminology C185182 Master File or Application Approved Indicator An approved indicator for an application or a master file when the Expiration Date Classification or Retest Date Classification is set to "Approved". Approved After an application or a master file has been approved, then the Expiration Date Classification or Retest Date Classification is set to "Approved". A C185181 PQ/CMC Expiration Date Classification Terminology C185186 Adequate Substance Process Understanding The applicant has appropriate process understanding to demonstrate that the quality of the subsequent API can be satisfactorily controlled. Adequate applies to substances only. Adequate The applicant has appropriate process understanding to demonstrate that the quality of the subsequent API can be satisfactorily controlled. Adequate applies to substances only. A C185181 PQ/CMC Expiration Date Classification Terminology C185188 Proposed Substance Date Change For a Supplement that's changing the expiration date or the retest date that is already classified as "Approved" for the drug product or drug substance, the changed expiration date classification or retest date classification would be "Proposed". Proposed For a Supplement that's changing the expiration date or the retest date that is already classified as "Approved" for the drug product or drug substance, the changed expiration date classification or retest date classification would be "Proposed". A C185183 PQ/CMC Retest Date Classification Terminology C185182 Master File or Application Approved Indicator An approved indicator for an application or a master file when the Expiration Date Classification or Retest Date Classification is set to "Approved". Approved After an application or a master file has been approved, then the Expiration Date Classification or Retest Date Classification is set to "Approved". A C185183 PQ/CMC Retest Date Classification Terminology C185186 Adequate Substance Process Understanding The applicant has appropriate process understanding to demonstrate that the quality of the subsequent API can be satisfactorily controlled. Adequate applies to substances only. Adequate The applicant has appropriate process understanding to demonstrate that the quality of the subsequent API can be satisfactorily controlled. Adequate applies to substances only. A C185183 PQ/CMC Retest Date Classification Terminology C185188 Proposed Substance Date Change For a Supplement that's changing the expiration date or the retest date that is already classified as "Approved" for the drug product or drug substance, the changed expiration date classification or retest date classification would be "Proposed". Proposed For a Supplement that's changing the expiration date or the retest date that is already classified as "Approved" for the drug product or drug substance, the changed expiration date classification or retest date classification would be "Proposed". A C185189 PQ/CMC Interval Description Code Terminology C96150 Immediate Testing Sample is tested immediately. Immediate Testing Sample is tested immediately. A C185189 PQ/CMC Interval Description Code Terminology C96151 Delayed Testing Sample is not tested immediately. Delayed Testing Sample is not tested immediately. A C185189 PQ/CMC Interval Description Code Terminology C96153 Frozen Delayed Testing Sample is frozen and not tested immediately. Frozen Delayed Testing Sample is frozen and not tested immediately. A C185189 PQ/CMC Interval Description Code Terminology C96154 Ambient Delayed Testing Sample is stored at ambient conditions and not tested immediately. Ambient Delayed Testing Sample is stored at ambient conditions and not tested immediately. A C185189 PQ/CMC Interval Description Code Terminology C96155 Refrigerated Delayed Testing Sample is refrigerated and not tested immediately. Refrigerated Delayed Testing Sample is refrigerated and not tested immediately. C C133860 PQ/CMC Quality Benchmark Terminology C134006 United States Pharmacopeia-National Formulary An official publication managed and maintained by the US Pharamacopeial Convention, that gives the composition, description, method of preparation, and dosage for drugs. USP-NF An official publication managed and maintained by the US Pharamacopeial Convention, that gives the composition, description, method of preparation, and dosage for drugs. C C133858 PQ/CMC Interpretation Code (numeric) Terminology C48793 Equivalent A person or thing equal to another in value or measure or force or effect or significance etc.; being essentially equal to something. EQ C C133859 PQ/CMC Manufacturing Site Unique Identifier Type Terminology C17998 Unknown Not known, observed, recorded; or reported as unknown by the data contributor. Unknown Not known, not observed, not recorded, or refused. C C133869 PQ/CMC Testing Site Unique Identifier Type Terminology C17998 Unknown Not known, observed, recorded; or reported as unknown by the data contributor. Unknown Not known, not observed, not recorded, or refused. C C168622 PQ/CMC Strength Operator Terminology C48793 Equivalent A person or thing equal to another in value or measure or force or effect or significance etc.; being essentially equal to something. EQ C C168624 PQ/CMC Sponsor Identifier Type Terminology C17998 Unknown Not known, observed, recorded; or reported as unknown by the data contributor. Unknown Not known, not observed, not recorded, or refused. C C176677 PQ/CMC Units of Measure Terminology C67328 Nanometer A metric unit of length equal to one billionth of a meter (10E-9 meter). Nanometer is used as a unit for light wavelength measurement. nm nanometer C C133856 PQ/CMC Impurity Classification Terminology C176812 Process Related Impurity Impurities that are derived from the manufacturing process. They may be derived from cell substrates (e.g., host cell proteins, host cell DNA), cell culture (e.g., inducers, antibiotics, or media components), or downstream processing (e.g., processing reagents or column leachables), or starting materials. Process Related/Process Impurities that are derived from the manufacturing process. [Source: SME Defined] Examples: Small molecules -- starting materials, intermediates, antibiotics, or media components, by-products, etc. Large molecules -- They may be derived from cell substrates (e.g., host cell proteins, host cell DNA), cell culture (e.g., inducers, antibiotics, or media components), or downstream processing (e.g., processing reagents or resin leachables). C C133807 PQ/CMC Test Category Terminology C176811 Physico-Chemical Properties The characteristics of a material associated with its composition and basic nature, including but not limited to its texture, smell, freezing point, boiling point, melting point, opacity, viscosity and density. Physico-Chemical Properties Assessments of the characteristics of a material that are not associated with a change in its composition and basic nature, including but not limited to its texture, smell, freezing point, boiling point, melting point, opacity, viscosity and density. C C133849 PQ/CMC Closure Type Terminology C96125 Crown Metal Container Closure A non-threaded shallow draw metal closure that normally has 21 corrugations on the outer edge, which function to engage the container when applied. The crown is only 1/4" high when manufactured and does not have a rolled edge or wire. The crown is manufactured 26mm worldwide and can be applied to either a threaded finish or a solid ring pry-off finish. Crown, Metal A non-threaded shallow draw metal closure that normally has 21 corrugations on the outer edge, which function to engage the container when applied. The crown is only 1/4\ high when manufactured and does not have a rolled edge or wire. The crown is manufactured 26mm worldwide and can be applied to either a threaded finish or a solid ring pry-off finish. C C133856 PQ/CMC Impurity Classification Terminology C176813 Product Related Impurity Molecular variants of the desired product (e.g., precursors, certain degradation products arising during manufacture and/or storage) which do not have properties comparable to those of the desired product with respect to activity, efficacy, and safety. Product Related Molecular variants of the desired product (e.g., precursors, certain degradation products arising during manufacture and/or storage) which do not have properties comparable to those of the desired product with respect to activity, efficacy, and safety. [Source: ICH Q6B] C C133865 PQ/CMC Storage Conditions Terminology C133935 Temperature 5 (+/-) 3 Degrees C Storage at 5 degrees C (+/-) 3 degrees C. 5 +/- 3 degrees C Storage at 5 degrees C (+/-) 3 degrees C. C C133865 PQ/CMC Storage Conditions Terminology C133936 Temperature -20 (+/-) 5 Degrees C Storage at -20 degrees C (+/-) 5 degrees C. -20 +/- 5 degrees C Storage at -20 degrees C (+/-) 5 degrees C. C C133865 PQ/CMC Storage Conditions Terminology C134014 Temperature 25 (+/-) 2 Degrees C and Relative Humidity 60% (+/-) 5% Storage at 25 degrees C (+/-) 2 degrees C and 60% Relative Humidity (+/-) 5% Relative Humidity. 25 +/- 2 degrees C/60% +/- 5%RH Storage at 25 degrees C (+/-) 2 degrees C and 60% Relative Humidity (+/-) 5% Relative Humidity. C C133865 PQ/CMC Storage Conditions Terminology C134015 Temperature 30 (+/-) 2 Degrees C and Relative Humidity 65% (+/-) 5% Storage at 30 degrees C (+/-) 2 degrees C and 65% Relative Humidity (+/-) 5% Relative Humidity. 30 +/- 2 degrees C/65% +/- 5%RH Storage at 30 degrees C (+/-) 2 degrees C and 65% Relative Humidity (+/-) 5% Relative Humidity. C C133865 PQ/CMC Storage Conditions Terminology C134016 Temperature 40 (+/-) 2 Degrees C and Relative Humidity 75% (+/-) 5% Storage at 40 degrees C (+/-) 2 degrees C and 75% Relative Humidity (+/-) 5% Relative Humidity. 40 +/- 2 degrees C/75% +/- 5%RH Storage at 40 degrees C (+/-) 2 degrees C and 75% Relative Humidity (+/-) 5% Relative Humidity. C C133865 PQ/CMC Storage Conditions Terminology C134017 Temperature 30 (+/-) 2 Degrees C and Relative Humidity 75% (+/-) 5% Storage at 30 degrees C (+/-) 2 degrees C and 75% Relative Humidity (+/-) 5% Relative Humidity. 30 +/- 2 degrees C/75% +/- 5%RH Storage at 30 degrees C (+/-) 2 degrees C and 75% Relative Humidity (+/-) 5% Relative Humidity. C C133865 PQ/CMC Storage Conditions Terminology C96148 Proprietary Storage Condition Storage conditions according to protocols set by a business or company. Proprietary Storage conditions according to protocols set by a business or company. C C133870 PQ/CMC Validation Parameter Terminology C134032 Analyte Specificity The ability to assess unequivocally the analyte in the presence of other components which may be expected to be present. Specificity The ability to assess unequivocally the analyte in the presence of other components which may be expected to be present. C C133870 PQ/CMC Validation Parameter Terminology C134033 Analytical Procedure Linearity The ability (within a given range) to obtain test results which are directly proportional to the concentration (amount) of analyte in a sample. Linearity The ability (within a given range) to obtain test results which are directly proportional to the concentration (amount) of analyte in a sample. C C133870 PQ/CMC Validation Parameter Terminology C134240 Analytical Procedure Range The interval between the upper and lower concentration (amounts) of analyte in the sample (including these concentrations) for which it has been demonstrated that the analytical procedure has a suitable level of precision, accuracy and linearity. Range The interval between the upper and lower concentration (amounts) of analyte in the sample (including these concentrations) for which it has been demonstrated that the analytical procedure has a suitable level of precision, accuracy and linearity. C C133870 PQ/CMC Validation Parameter Terminology C134242 Analytical Procedure Accuracy The closeness of agreement between the value which is accepted either as a conventional true value or an accepted reference value and the value found. Accuracy The closeness of agreement between the value which is accepted either as a conventional true value or an accepted reference value and the value found. C C133870 PQ/CMC Validation Parameter Terminology C134243 Analytical Procedure Precision The closeness of agreement (degree of scatter) between a series of measurements obtained from multiple sampling of the same homogeneous sample under the prescribed conditions. Precision may be considered at three levels: repeatability, intermediate precision and reproducibility. Precision The closeness of agreement (degree of scatter) between a series of measurements obtained from multiple sampling of the same homogeneous sample under the prescribed conditions. Precision may be considered at three levels: repeatability, intermediate precision and reproducibility. C C133870 PQ/CMC Validation Parameter Terminology C134244 Analytical Procedure Detection Limit The lowest amount of analyte in a sample which can be detected but not necessarily quantitated as an exact value. Detection Limit The lowest amount of analyte in a sample which can be detected but not necessarily quantitated as an exact value. C C133870 PQ/CMC Validation Parameter Terminology C134245 Analytical Procedure Robustness The measure of a procedure's capacity to remain unaffected by small, but deliberate variations in method parameters and provides an indication of its reliability during normal usage. Robustness The measure of a procedure's capacity to remain unaffected by small, but deliberate variations in method parameters and provides an indication of its reliability during normal usage. C C133870 PQ/CMC Validation Parameter Terminology C134246 System Suitability The tests are based on the concept that the equipment, electronics, analytical operations, and samples to be analyzed constitute an integral system that can be evaluated as such. System suitability test parameters to be established for a particular procedure depend on the type of procedure being validated. System Suitability The tests are based on the concept that the equipment, electronics, analytical operations, and samples to be analyzed constitute an integral system that can be evaluated as such. System suitability test parameters to be established for a particular procedure depend on the type of procedure being validated. C C133870 PQ/CMC Validation Parameter Terminology C134248 Analytical Procedure Quantitation Limit The lowest amount of analyte in a sample which can be quantitatively determined with suitable precision and accuracy. Quantitation Limit The lowest amount of analyte in a sample which can be quantitatively determined with suitable precision and accuracy. C C176676 PQ/CMC Excipient Function Terminology C176653 Matrix Forming Excipient A polymer within a sustained-release formulation that maintains matrix rigidity over a prolonged period. Matrix-forming agent Polymers added to sustained release formulations to control and maintain the rigidity of the matrix over a prolonged period (e.g. sustained-release agent; matrix for sustained release; rate-controlling polymer for sustained release). (Adapted from \The Role of Oral Controlled Release Matrix Tablets in Drug Delivery Systems\, Ali Nokhodchi1, Shaista Raja1, Pryia Patel1, Kofi Asare-Addo BioImpacts, 2012, 2(4), 175-187) D C133856 PQ/CMC Impurity Classification Terminology C84280 Contaminant A substance that makes a material impure. Contaminants Contaminants in a product include all adventitiously introduced materials not intended to be part of the manufacturing process, such as chemical and biochemical materials, and/or microbial species. Examples: bisphenol-A diglycidyl ether (BADGE), bisphenol A (BPA, isopropyl acetophenone, microbial proteases, endotoxin, etc. D C176790 PQ/CMC Process Related Impurity Category Terminology C134000 Organic Impurity Any unwanted organic compound that is present in specifically defined substances or products and is generated during the manufacturing process or is created upon degradation during storage. Organic Materials that are degradation products or residuals and are generated during a manufacturing process or storage. [Source: Adapted form ICH Q3A(R2)] D C176790 PQ/CMC Process Related Impurity Category Terminology C134001 Inorganic Impurity Any unwanted inorganic compound generated during the manufacturing process of a particular substance or product. Inorganic Materials that are not carbon-based and are generated during a manufacturing process that are not part of elemental impurity specification. D C176790 PQ/CMC Process Related Impurity Category Terminology C176815 Residual Solvent Inorganic or organic liquids added during the manufacturing process. Residual Solvent Inorganic or organic liquids added during the manufacturing process. [Source: Adapted from ICH Q3A(R2)] D C176814 PQ/CMC Product Related Impurity Category Terminology C176813 Product Related Impurity Molecular variants of the desired product (e.g., precursors, certain degradation products arising during manufacture and/or storage) which do not have properties comparable to those of the desired product with respect to activity, efficacy, and safety. Product Related Molecular variants of the desired product (e.g., precursors, certain degradation products arising during manufacture and/or storage) which do not have properties comparable to those of the desired product with respect to activity, efficacy, and safety. D C176814 PQ/CMC Product Related Impurity Category Terminology C176816 Degradant An impurity resulting from a chemical change in the drug substance. Degradants An impurity resulting from a chemical change in the drug substance [Source: Adapted from ICH Q3B(R2)] Example: Aggregates, Truncated Form, etc.